Tenon Medical, Inc. Stock Price, News & Analysis

Welcome to our dedicated page for Tenon Medical news (Ticker: TNON), a resource for investors and traders seeking the latest updates and insights on Tenon Medical stock.

Tenon Medical, Inc. (NASDAQ: TNON) is a medical device company focused on minimally invasive sacroiliac (SI) joint and sacro-pelvic fusion technologies. News about Tenon often centers on its Catamaran SI Joint Fusion System, the Catamaran SE reduced-profile implant, and the SImmetry and SImmetry+ SI Joint Fusion Systems acquired through the SiVantage transaction. These platforms are designed to stabilize the SI joint and promote true fusion using titanium implants and proprietary instrumentation.

Investors and clinicians following TNON news can expect updates on product clearances, commercial launches and clinical milestones. Recent announcements include FDA 510(k) clearance for the SImmetry+ SI Joint Fusion System, which uses 3D-printed titanium implants and a minimally invasive lateral access approach, and the successful completion of initial clinical cases with SImmetry+ at spine centers across multiple U.S. states. Tenon also reports on the full market launch of the Catamaran SE SI Joint Fusion System, expanding its implant portfolio with a smaller device option for varying anatomy and revision scenarios.

Tenon’s news flow also covers financial performance and capital markets activity. Quarterly earnings releases discuss revenue from Catamaran and SImmetry procedures, gross margin trends, operating expenses, and cash balances, as well as integration progress for acquired assets and commercial expansion. The company has announced at‑the‑market PIPE financings, detailed in both press releases and Form 8‑K filings, describing share and warrant issuances and intended use of proceeds for working capital, product launches, clinical studies and commercial operations.

Corporate updates in TNON news include asset purchase agreements for sacro-pelvic technologies, employment agreements with key commercial and innovation leaders, and governance matters such as annual meeting voting results and equity incentive plan amendments. For readers tracking developments in SI joint fusion devices, Tenon’s news page provides a centralized view of regulatory, clinical, commercial and financing events related to its sacro-pelvic fusion portfolio.